title: [Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].
authors.affiliation: H:S Frederiksberg Hospital, Kardiologisk-endokrinologisk Klinik E, og Aker Universitetshospital, Kardiologisk Afdeling, Oslo.
authors.forename: Morten
authors.initials: M
authors.lastname: Svensson
authors.forename: Finn
authors.initials: F
authors.lastname: Gustafsson
authors.forename: Søren
authors.initials: S
authors.lastname: Galatius
authors.forename: Per R
authors.initials: PR
authors.lastname: Hildebrandt
authors.forename: Dan
authors.initials: D
authors.lastname: Atar
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004232:Diuretics / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013148:Spironolactone / Q000009:adverse effects*
chemical_list: D004232:Diuretics; D013148:Spironolactone
vernacular_title: Hyperkaliaemi og reduceret nyrefunktion hos hjerteinsufficiente patienter under behandling med spironolacton. En retrospektiv analyse af 125 konsekutivt valgte patienter.